| 1 |
34278466 | Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer. | 2021 Sep |
3 |
| 2 |
26840567 | Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients. | 2016 Mar 8 |
2 |
| 3 |
27462592 | The effect of salinomycin on ovarian cancer stem-like cells. | 2016 Jul |
2 |
| 4 |
27502704 | Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA. | 2016 Oct |
1 |
| 5 |
26177978 | Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy. | 2015 Oct |
2 |
| 6 |
24431074 | Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study. | 2014 Mar |
1 |
| 7 |
24782986 | Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden. | 2014 |
1 |
| 8 |
22797058 | c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling. | 2013 May 30 |
1 |
| 9 |
20975605 | Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor. | 2011 Feb |
1 |
| 10 |
18751412 | Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma. | 2008 Jul-Aug |
1 |